NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 1,056.00
-43.10 (-3.92%)
At close: Apr 21, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 189.08 billion as of April 21, 2026. Its market cap has increased by 28.31% in one year.
Market Cap
189.08B
Enterprise Value
159.69B
Revenue
45.63B
Ranking
n/a
PE Ratio
12.14
Stock Price
1,056.00
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 189.08B, an increase of 43,934.09%. That is a compound annual growth rate of 25.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 189.08B | 16.90% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 412.01B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 164.48B |
| Rubicon Research | 148.09B |
| Jubilant Pharmova | 144.39B |
| Caplin Point Laboratories | 134.73B |
| CORONA Remedies | 103.87B |